Introduction In recent years, the United States has witnessed a surge in interest regarding alternative treatments for treatment-resistant depression (TRD). Among the most promising are psilocybin and ibogaine, two naturally occurring psychedelics that are reshaping the landscape of mental health care. While these substances are not yet approved for widespread medical use in the U.S., […]